NEW YORK (GenomeWeb) – Sygnis announced yesterday that it has signed a distribution agreement with China's Nanodigmbio.
Under the terms of the agreement, Nanodigmbio gains the rights to promote, market, and sell all existing and future Syngis products, including TruePrime reagents for primer-free whole genome amplification and SunScript reverse transcriptase kits, in China.
"[W]ith Nanodigmbio we are pursuing an aggressive strategy to enter this market," Sygnis CEO Pilar de la Heurta said in a statement. "In parallel we are negotiating with key sequencing companies in China to provide them with our kits for their sequencing services."
Financial and other terms of the deal were not disclosed.
In June, Sygnis signed a non-exclusive deal with Welgene to distribute the firm's products in Taiwan. This year, Sygnis has signed distribution deals for Canada, Japan, France, Belgium, the UK and Ireland, and Scandinavia.